Search Count: 11
 |
Orexin Receptor 2 (Ox2R) In Complex With G Protein And Natural Peptide-Agonist Orexin B (Oxb)
Organism: Homo sapiens, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2021-02-10 Classification: MEMBRANE PROTEIN |
 |
Orexin Receptor 2 (Ox2R) In Complex With G Protein And Small-Molecule Agonist Compound 1
Organism: Homo sapiens, Mus musculus, Lama glama
Method: ELECTRON MICROSCOPY Release Date: 2021-02-10 Classification: MEMBRANE PROTEIN Ligands: XGD |
 |
Xfel Structure Of Human Angiotensin Ii Type 2 Receptor (Monoclinic Form) In Complex With Compound 1 (N-Benzyl-N-(2-Ethyl-4-Oxo-3-{[2'-(2H-Tetrazol-5-Yl)[1,1'-Biphenyl]-4-Yl])
Organism: Escherichia coli, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2017-04-05 Classification: SIGNALING PROTEIN Ligands: 8ES |
 |
Xfel Structure Of Human Angiotensin Ii Type 2 Receptor (Orthorhombic Form) In Complex With Compound 1 (N-Benzyl-N-(2-Ethyl-4-Oxo-3-{[2'-(2H-Tetrazol-5-Yl)[1,1'-Biphenyl]-4-Yl] Methyl}-3,4-Dihydroquinazolin-6-Yl)Thiophene-2-Carboxamide)
Organism: Escherichia coli, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2017-04-05 Classification: SIGNALING PROTEIN Ligands: 8ES, OLC, OLA |
 |
Synchrotron Structure Of Human Angiotensin Ii Type 2 Receptor In Complex With Compound 2 (N-[(Furan-2-Yl)Methyl]-N-(4-Oxo-2-Propyl-3-{[2'-(2H-Tetrazol-5-Yl)[1,1'- Biphenyl]-4-Yl]Methyl}-3,4-Dihydroquinazolin-6-Yl)Benzamide)
Organism: Escherichia coli, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2017-04-05 Classification: SIGNALING PROTEIN Ligands: 8EM |
 |
Identification Of Lxrbeta Selective Agonists For The Treatment Of Alzheimer'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2016-04-06 Classification: SIGNALING PROTEIN Ligands: 668, PEG |
 |
Identification Of Lxrbeta Selective Agonists For The Treatment Of Alzheimer'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2016-04-06 Classification: SIGNALING PROTEIN Ligands: 668, SO4 |
 |
The Structure Of Trka Kinase Bound To The Inhibitor N-(3-Cyclopropyl-1-Phenyl-1H-Pyrazol-5-Yl)-2-{4-[3-Methoxy-4-(4-Methyl-1H-Imidazol-1-Yl)Phenyl]-1H-1,2,3-Triazol-1-Yl}Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-06-18 Classification: Transferase/Transferase inhibitor Ligands: 31V, GOL, CL, ACT |
 |
The Structure Of Trka Kinase Bound To The Inhibitor 1-Cyclopropyl-1-[3-(1,3-Thiazol-2-Yl)Benzyl]-3-[4-(Trifluoromethoxy)Phenyl]Urea
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-06-18 Classification: Transferase/Transferase inhibitor Ligands: 31W, CL, ACT |
 |
The Structure Of Trka Kinase Bound To The Inhibitor 4-Naphthalen-1-Yl-1-[(5-Phenyl-1,2,4-Oxadiazol-3-Yl)Methyl]-1H-Pyrrolo[3,2-C]Pyridine-2-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2014-06-18 Classification: Transferase/Transferase inhibitor Ligands: 31X, CL, ACT |
 |
The Structure Of Trka Kinase Bound To The Inhibitor N~4~-(4-Morpholin-4-Ylphenyl)-N~6~-(Pyridin-3-Ylmethyl)Pyrido[3,2-D]Pyrimidine-4,6-Diamine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2014-06-18 Classification: Transferase/Transferase inhibitor Ligands: 31Y, CL, ACT |